This website is for Healthcare Professionals
Report Adverse Event
Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
Adverse events should also be reported to AbbVie at:
ABBV-RO-00032-MC. Date of preparation: December 2020